These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Prevention of 1-methyl-4-phenylpyridinium- and 6-hydroxydopamine-induced nitration of tyrosine hydroxylase and neurotoxicity by EUK-134, a superoxide dismutase and catalase mimetic, in cultured dopaminergic neurons. Pong K; Doctrow SR; Baudry M Brain Res; 2000 Oct; 881(2):182-9. PubMed ID: 11036157 [TBL] [Abstract][Full Text] [Related]
23. An in vitro model of human dopaminergic neurons derived from embryonic stem cells: MPP+ toxicity and GDNF neuroprotection. Zeng X; Chen J; Deng X; Liu Y; Rao MS; Cadet JL; Freed WJ Neuropsychopharmacology; 2006 Dec; 31(12):2708-15. PubMed ID: 17109014 [TBL] [Abstract][Full Text] [Related]
24. Ghrelin prevents 1-methyl-4-phenylpyridinium ion-induced cytotoxicity through antioxidation and NF-kappaB modulation in MES23.5 cells. Liu L; Xu H; Jiang H; Wang J; Song N; Xie J Exp Neurol; 2010 Mar; 222(1):25-9. PubMed ID: 19931250 [TBL] [Abstract][Full Text] [Related]
25. Diethyldithiocarbamate potentiates the neurotoxicity of in vivo 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine and of in vitro 1-methyl-4-phenylpyridinium. Miller DB; Reinhard JF; Daniels AJ; O'Callaghan JP J Neurochem; 1991 Aug; 57(2):541-9. PubMed ID: 1649252 [TBL] [Abstract][Full Text] [Related]
26. A redox reaction between MPP+ and MPDP+ to produce superoxide radicals does not impair mitochondrial function. Walker MJ; Jenner P; Marsden CD Biochem Pharmacol; 1991 Jul; 42(4):913-9. PubMed ID: 1651082 [TBL] [Abstract][Full Text] [Related]
27. Inhibition of brain vesicular monoamine transporter (VMAT2) enhances 1-methyl-4-phenylpyridinium neurotoxicity in vivo in rat striata. Staal RG; Sonsalla PK J Pharmacol Exp Ther; 2000 May; 293(2):336-42. PubMed ID: 10773000 [TBL] [Abstract][Full Text] [Related]
28. Curcumin protects mouse brain from oxidative stress caused by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. Rajeswari A Eur Rev Med Pharmacol Sci; 2006; 10(4):157-61. PubMed ID: 16910344 [TBL] [Abstract][Full Text] [Related]
29. Lowering ambient or core body temperature elevates striatal MPP+ levels and enhances toxicity to dopamine neurons in MPTP-treated mice. Moy LY; Albers DS; Sonsalla PK Brain Res; 1998 Apr; 790(1-2):264-9. PubMed ID: 9593931 [TBL] [Abstract][Full Text] [Related]
30. Neuroprotective effect of metformin in MPTP-induced Parkinson's disease in mice. Patil SP; Jain PD; Ghumatkar PJ; Tambe R; Sathaye S Neuroscience; 2014 Sep; 277():747-54. PubMed ID: 25108167 [TBL] [Abstract][Full Text] [Related]
31. Release of dopamine by perfusion with 1-methyl-4-phenylpyridinium ion (MPP(+)) into the striatum is associated with hydroxyl free radical generation. Obata T; Yamanaka Y; Kinemuchi H; Oreland L Brain Res; 2001 Jul; 906(1-2):170-5. PubMed ID: 11430875 [TBL] [Abstract][Full Text] [Related]
32. Neuroprotective effect of catalpol against MPP(+)-induced oxidative stress in mesencephalic neurons. Tian YY; Jiang B; An LJ; Bao YM Eur J Pharmacol; 2007 Jul; 568(1-3):142-8. PubMed ID: 17512520 [TBL] [Abstract][Full Text] [Related]
33. Activation of Nrf2 by methylene blue is associated with the neuroprotection against MPP Bhurtel S; Bok E; Katila N; Kim J; Choi DY Biochem Pharmacol; 2021 Oct; 192():114719. PubMed ID: 34352280 [TBL] [Abstract][Full Text] [Related]
34. K(ATP) channel openers protect mesencephalic neurons against MPP+-induced cytotoxicity via inhibition of ROS production. Xie J; Duan L; Qian X; Huang X; Ding J; Hu G J Neurosci Res; 2010 Feb; 88(2):428-37. PubMed ID: 19746425 [TBL] [Abstract][Full Text] [Related]
35. Increased striatal lipid peroxidation after intracerebroventricular MPP+ administration to mice. Rojas P; Rios C Pharmacol Toxicol; 1993 Jun; 72(6):364-8. PubMed ID: 8361947 [TBL] [Abstract][Full Text] [Related]
36. Sesamin modulates tyrosine hydroxylase, superoxide dismutase, catalase, inducible NO synthase and interleukin-6 expression in dopaminergic cells under MPP+-induced oxidative stress. Lahaie-Collins V; Bournival J; Plouffe M; Carange J; Martinoli MG Oxid Med Cell Longev; 2008; 1(1):54-62. PubMed ID: 19794909 [TBL] [Abstract][Full Text] [Related]
37. Manganese superoxide dismutase overexpression attenuates MPTP toxicity. Klivenyi P; St Clair D; Wermer M; Yen HC; Oberley T; Yang L; Flint Beal M Neurobiol Dis; 1998 Oct; 5(4):253-8. PubMed ID: 9848095 [TBL] [Abstract][Full Text] [Related]
38. Neuroprotective actions of Selegiline in inhibiting 1-methyl, 4-phenyl, pyridinium ion (MPP+)-induced apoptosis in SK-N-SH neurons. Sharma SK; Carlson EC; Ebadi M J Neurocytol; 2003 May; 32(4):329-43. PubMed ID: 14724376 [TBL] [Abstract][Full Text] [Related]
39. Metabolism of [14C]MPTP in mouse and monkey implicates MPP+, and not bound metabolites, as the operative neurotoxin. Yang SC; Johannessen JN; Markey SP Chem Res Toxicol; 1988; 1(4):228-33. PubMed ID: 2979736 [TBL] [Abstract][Full Text] [Related]
40. β-Estradiol-3-benzoate confers neuroprotection in Parkinson MPP Aguirre-Vidal Y; Monroy-Noyola A; Anaya-Ramos L; Arteaga-Silva M; Mendez-Armenta M; Ostoa-Saloma P; Díaz-Zaragoza M; Morales-Montor J; Ríos C; Montes S Steroids; 2017 Oct; 126():7-14. PubMed ID: 28827046 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]